ECS Botanics (ASX:ECS) - Founder and MD, Alex Keach
Founder and MD, Alex Keach
Source: ECS Botanics
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • ECS Botanics (ECS) is set to stock its Extra Virgin Tasmanian Hemp Seed Oil product in Coles stores nationwide
  • The product is expected to be on shelves in October and will be stocked in the cooking oil section
  • Hemp seed oil is becoming more popular due to its environmentally friendly source of Omega 3 and its anti-inflammatory properties
  • Total revenue is uncertain at this time and no minimum volumes have yet to be confirmed
  • Shares in ECS are up 9.09 per cent, trading at 3.6 cents at 12:44 pm AEST

ECS Botanics (ECS) is set to sell its Extra Virgin Tasmanian Hemp Seed Oil product in Coles stores nationwide.

The product will be stocked in a number of Coles’ 2500 stores from October.

ECS will no longer use Just Food Australia for the distribution of its products which allows it to achieve significantly higher margins.

The hemp seed oil product will be stocked in the cooking oil section of Coles. It can be used in cooking, salads, smoothies and baking.

Hemp seed oil is becoming more popular due to its environmental source of Omega 3 and its anti-inflammatory properties.

Total revenue is uncertain at this time and no minimum volumes have yet to be confirmed.

Managing Director Alex Keach is excited with the partnership and believes the product will be well received.

“We are delighted to be supplying Coles with our premium hemp seed oil product and are confident the product will be well received by consumers,” Mr Keach said.

“As the largest retail supplier of oil in the country, we are witnessing demand for hemp seed oil steadily increase and to now have the product stocked with two of Australia’s largest supermarket retailers, we are well positioned to capitalise on market demand.

“Now that we have established a direct relationship with supermarket groups, we will take advantage of the opportunity to extend the number of products ranged with these retailers.”

Shares in ECS were up 9.09 per cent, trading at 3.6 cents at 12:44 pm AEST.

ECS by the numbers
More From The Market Online
The Market Online Video

Listen: From the Wire – Paradigm Biopharma CEO and Founder Paul Rennie

From The Wire: Senior markets reporter Jonathon Davidson sat down with Paradigm Biopharmaceuticals chief executive officer…
Lung imaging concept

Biotech lung imaging darling 4DX Medical back at $2.20/sh on Miami U contract

4DX Medical has seen its price jump back to $2.20/sh, as its next-gen lung imaging scan…
Chuffed bloke

Race Oncology’s placement-at-a-premium rewarded as shares jump +8%

Race Oncology has completed its recent A$3.2M placement – something that shareholders on the HotCopper forums…

Effective as an IV drug, a gel, and now an inhaler – Recce’s R327 can’t stop winning

Recce flagship antibacertial and anti-infective drug R327 has in a model that shows the drug could…